PCK 8.33% 3.9¢ painchek ltd

Ann: Appendix 4D & Financial Statements, page-13

  1. 6,680 Posts.
    lightbulb Created with Sketch. 4385
    That second row tells the story of how Covid has impact on the roll out. Nothing scary about it. Just mere fact that the Covid has impact on all businesses.

    Regardless, I love the clear financial report with regards to the future. And the fact that the company is very transparent here with regard to this statement:

    "...and the forward-looking revenue equates to more than $3M Annualized Recurring Revenue (assuming client contracts are renewed) post the government grant."

    That is something we can keep an eye on. If there is basically no churn, then we should see the $3m ARR for the next financial year.

    Reading through the report, there are lots of stuff to happen in 2021, barring any Covid-like impact. So, all in all, a pretty good report, with a well laid out business plan in the work.
 
watchlist Created with Sketch. Add PCK (ASX) to my watchlist
(20min delay)
Last
3.9¢
Change
0.003(8.33%)
Mkt cap ! $63.79M
Open High Low Value Volume
3.8¢ 3.9¢ 3.7¢ $22.05K 582.2K

Buyers (Bids)

No. Vol. Price($)
1 200000 3.6¢
 

Sellers (Offers)

Price($) Vol. No.
3.9¢ 165999 2
View Market Depth
Last trade - 16.10pm 09/08/2024 (20 minute delay) ?
PCK (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.